Ankylosing spondylitis
Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial
Juvenile-onset ankylosing spondylitis is associated with worse functional outcomes than adult-onset ankylosing spondylitis
ANKYLOSING SPONDYLITIS
Ankylosing Spondylitis
Inflammatory Spondylitis